{
    "clinical_study": {
        "@rank": "90564", 
        "arm_group": [
            {
                "arm_group_label": "Midodrine", 
                "arm_group_type": "Experimental", 
                "description": "Midodrine Hydrochloride (5mg) administered as capsule 5 and 23 hours after end of surgery."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo administered as capsule 5- and 23 hours after end of surgery."
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this study is to examine the efficacy of 5 mg Midodrine (Gutron) vs. placebo on\n      reducing the incidence of orthostatic hypotension during mobilization 6 h after a total hip\n      arthroplasty."
        }, 
        "brief_title": "Efficacy of Midodrine for the Prevention of Orthostatic Hypotension During Early Mobilization After Fast-track Hip Arthroplasty", 
        "completion_date": {
            "#text": "September 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Postoperative Orthostatic Hypotension", 
            "Postoperative Orthostatic Intolerance"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Hypotension", 
                "Hypotension, Orthostatic", 
                "Orthostatic Intolerance", 
                "Mitral Valve Prolapse", 
                "Neurocirculatory Asthenia"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Scheduled for primary unilateral hip arthroplasty\n\n          -  Age >= 18 years\n\n          -  Able to give informed consent\n\n        Exclusion Criteria:\n\n          -  General anaesthesia for the current procedure\n\n          -  Digoxin treatment.\n\n          -  history of renal or hepatic failure\n\n          -  history of glaucoma\n\n          -  history chronic urinary retention requiring treatment\n\n          -  history of orthostatic intolerance / hypotension\n\n          -  other autonomous nervous system disease\n\n          -  alcohol or drug abuse\n\n          -  current malignant disease\n\n          -  females in the fertile age (possible pregnancy or breast feeding)\n\n          -  Treatment with anticoagulants\n\n          -  BMI > 40 kg/m2\n\n          -  Dementia or cognitive dysfunction (investigators evaluation)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 10, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01707953", 
            "org_study_id": "RH-4074-OJ1", 
            "secondary_id": "2012-002572-13"
        }, 
        "intervention": [
            {
                "arm_group_label": "Midodrine", 
                "description": "Midodrine 5mg as capsule, administered twice (5 and 23 hours after end of surgery).", 
                "intervention_name": "Midodrine", 
                "intervention_type": "Drug", 
                "other_name": "Gutron"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Placebo capsule to mimic midodrine", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Midodrine"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 17, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Hellerup", 
                        "country": "Denmark", 
                        "zip": "2900"
                    }, 
                    "name": "Gentofte Hospital, Department of orthopaedic surgery"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hvidovre", 
                        "country": "Denmark", 
                        "zip": "2650"
                    }, 
                    "name": "Hvidovre Hospital, Department of orthopaedic surgery"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vejle", 
                        "country": "Denmark", 
                        "zip": "7100"
                    }, 
                    "name": "Vejle Sygehus, Department of orthopedic surgery"
                }
            }
        ], 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "official_title": "Efficacy of Midodrine for the Prevention of Orthostatic Hypotension During Early Mobilization After Fast-track Hip Arthroplasty - a Randomized, Placebo Controlled Trial.", 
        "other_outcome": [
            {
                "description": "Haemodynamic response to mobilization (supine, sitting and standing):\nResponse in systolic and diastolic blood pressure\nResponse in heart rate.\nResponse in calculated haemodynamic variables (stroke volume, peripheral resistance)", 
                "measure": "Haemodynamic response to mobilization 6 and 24 hours after surgery", 
                "safety_issue": "No", 
                "time_frame": "6 and 24 hours after end of surgery"
            }, 
            {
                "description": "Heart rate variability measures including spectral analysis and LF/HF ratio at rest and during mobilization.", 
                "measure": "Heart rate variability", 
                "safety_issue": "No", 
                "time_frame": "before surgery, 6- and 24 hours after surgery"
            }
        ], 
        "overall_official": [
            {
                "affiliation": "Rigshospitalet, Section for Surgical Pathophysiology", 
                "last_name": "Henrik Kehlet, Proffessor", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Rigshospitalet, Section for Surgical Pathophysiology", 
                "last_name": "Oeivind Jans, M.D.", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Denmark: Danish Medicines Agency", 
                "Denmark: Danish Dataprotection Agency"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "September 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Orthostatic hypotension (OH) during early mobilization 6 hours after end of surgery. OH is classified according to international consensus.", 
            "measure": "Orthostatic hypotension", 
            "safety_issue": "No", 
            "time_frame": "6 hours after surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01707953"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Rigshospitalet, Denmark", 
            "investigator_full_name": "Oeivind Jans", 
            "investigator_title": "M.D, Research Fellow", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Orthostatic hypotension 24 hours after surgery", 
                "safety_issue": "No", 
                "time_frame": "24 hours after end of surgery."
            }, 
            {
                "description": "Orthostatic intolerance is defined as subjective presyncopal symptoms (dizziness, nausea etc.) during mobilization after surgery", 
                "measure": "Orthostatic Intolerance", 
                "safety_issue": "No", 
                "time_frame": "6 and 24 hours after end of surgery"
            }, 
            {
                "description": "The following side effects to Midodrine are evaluated:\nPruritus\nHeadache\nSupine hypertension\nUrinary retention", 
                "measure": "Treatment side effects", 
                "safety_issue": "Yes", 
                "time_frame": "6 and 24 hours after end of surgery"
            }
        ], 
        "source": "Rigshospitalet, Denmark", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Rigshospitalet, Denmark", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}